Jagsonpal Pharmaceuticals Limited (JAGSNPHARM.NS)

INR 689.05

(0.15%)

Market Cap (In INR)

18.27 Billion

Revenue (In INR)

2.08 Billion

Net Income (In INR)

224.63 Million

Avg. Volume

86.57 Thousand

Currency
INR
Country
Healthcare
Open
-
Prev. Close
-
Day Range
-
Year Range
273.6-820.1
PE
-
EPS
-
Beta Value
1.055
ISIN
INE048B01027
CUSIP
Y4252X131
CIK
-
Shares
-
Earnings Annoncement
-

Company Profile

Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Mr. Manish Gupta
Employee Count
-
Website
https://www.jagsonpal.com
Ipo Date
2002-07-01
Details
Jagsonpal Pharmaceuticals Limited develops and manufactures bulk drugs and pharmaceutical formulations in the areas of women health, pain and analgesics, and general medicine. It offers general medicines, such as allergy management, immunity and cell protection, gut and mind management, anti-infectives, and dentist and ENT range products; and women's healthcare products, including pregnancy care, and dysfunctional uterine bleeding complications and management products. The company also provides pain and analgesics products in the areas of pain management, and bone and joint care. It offers drugs in the form of tablets, capsules, and syrups. The company was founded in 1964 and is based in New Delhi, India. Jagsonpal Pharmaceuticals Limited is a subsidiary of Aresko Progressive Private Limited.